Metabolic Bone Disorder Completed Phase 4 Trials for Denosumab (DB06643)

Also known as: Metabolic Bone Disease / Bone Disease, Metabolic / Bone Diseases, Metabolic / Metabolic Bone Diseases / Metabolic bone disorders / Metabolic bone disease (disorder) / Bone metabolism disorder / Bone metabolism disorders

IndicationStatusPhase
DBCOND0064775 (Metabolic Bone Disorder)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02853539Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure PatientsTreatment